<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="irv12670-tbl-0003" xml:lang="en" orientation="portrait" position="float">
 <label>Table 3</label>
 <caption>
  <p>Summary of experimental animal studies exploring the interaction between influenza and tuberculosis</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Reference</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Objective</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Experiment</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Influenza strain/TB</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Period/ observation period</th>
    <th align="left" valign="top" rowspan="1" colspan="1">Findings</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Volkert (1947)
     <xref rid="irv12670-bib-0020" ref-type="ref">20</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Does viral infection of the lungs superimposed on tubercle bacilli infection alter cause and outcome of infection due to bacterium</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Model: Mice 
      <list list-type="simple" id="irv12670-list-0002">
       <list-item>
        <p>1. Experiment group 1</p>
       </list-item>
      </list>
     </p>
     <p>Experimental group 
      <list list-type="bullet" id="irv12670-list-0003">
       <list-item>
        <p>Simultaneous TB bacilli given intraperitoneally and influenza A virus (PR8) intra nasally</p>
       </list-item>
      </list>
     </p>
     <p>Control group 1:</p>
     <p>Inoculated with TB only</p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0004">
       <list-item>
        <p>Number of gross tuberculosis pulmonary lesions measured at 3 wk</p>
       </list-item>
      </list>
     </p>
     <p>Experiment group 2: 
      <list list-type="bullet" id="irv12670-list-0005">
       <list-item>
        <p>Inoculation with TB bacilli and influenza 3 wk later</p>
       </list-item>
      </list>
     </p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0006">
       <list-item>
        <p>Number of gross TB pulmonary lesions measured 6 wk after TB infection (3 wk after influenza challenge)</p>
       </list-item>
      </list>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">Influenza A PR8/ culture of tubercle bacilli</td>
    <td align="left" rowspan="1" colspan="1">3 and 6 wk</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Experimental group 1 
      <list list-type="bullet" id="irv12670-list-0007">
       <list-item>
        <p>Increased number and extent of pulmonary lesions compared to control group</p>
       </list-item>
      </list>
     </p>
     <p>Experimental group 2: 
      <list list-type="bullet" id="irv12670-list-0008">
       <list-item>
        <p>Increased number and extent of pulmonary lesions compared to control group</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Florido (2013)
     <xref rid="irv12670-bib-0038" ref-type="ref">38</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">Assessed impact of influenza A virus and mycobacterial respiratory co‐infection on development of CD8 T‐cell responses to each pathogen</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Experiment 1</p>
     <p>Experimental group: 
      <list list-type="bullet" id="irv12670-list-0009">
       <list-item>
        <p>
         <italic>Mycobacterium bovis</italic> bacille Calmette‐Guerin (BCG) and influenza A/PR8 at D1
        </p>
       </list-item>
      </list>
     </p>
     <p>Control groups: 
      <list list-type="bullet" id="irv12670-list-0010">
       <list-item>
        <p>BCG only at D1</p>
       </list-item>
      </list>
     </p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0011">
       <list-item>
        <p>Number of BCG and influenza‐specific CD4 and CD8 T cells, number of mycobacteria, viral titres, and number of leucocytes at D7, D14 and D21 post‐infection</p>
       </list-item>
      </list>
     </p>
     <p>Experiment 2:</p>
     <p>Experimental group: 
      <list list-type="bullet" id="irv12670-list-0012">
       <list-item>
        <p>BCG at D1, and influenza infection at 7 wk</p>
       </list-item>
      </list>
     </p>
     <p>Control group: 
      <list list-type="bullet" id="irv12670-list-0013">
       <list-item>
        <p>BCG at D1, TB treatment at week 3 (for 4 wk) and influenza infection at 7 wk</p>
       </list-item>
      </list>
     </p>
     <p>Outcomes:</p>
     <p>BCG‐specific CD8 T‐cell response D21 post‐influenza</p>
    </td>
    <td align="left" rowspan="1" colspan="1">Influenza A/ PR8; BCG</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Experiment 1:7, 14, 21 d post‐infection;</p>
     <p>Experiment 2</p>
     <p>21 d post‐influenza challenge (challenge at 7 wk)</p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>Experiment 1 
      <list list-type="bullet" id="irv12670-list-0014">
       <list-item>
        <p>Experimental (co‐infected) group—reduced frequency and magnitude of BCG‐specific CD8 T cells in the lungs and reduced magnitude of BCG‐specific CD4 and CD8 T cell IFNγ—secreting responses; no difference in influenza‐specific CD8 T cells</p>
       </list-item>
       <list-item>
        <p>Co‐infected group had increased number of viable BCG ova</p>
       </list-item>
       <list-item>
        <p>Co‐infected group had more extensive/persistent leucocyte accumulation</p>
       </list-item>
      </list>
     </p>
     <p>Experiment 2‐ 
      <list list-type="bullet" id="irv12670-list-0015">
       <list-item>
        <p>Experimental group had reduced BCG‐ specific CD8 T‐cell response</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="2" colspan="1">Redford (2014)
     <xref rid="irv12670-bib-0039" ref-type="ref">39</xref>
    </td>
    <td align="left" rowspan="2" colspan="1">
     <p>1. Effect of prior IAV on susceptibility to tuberculosis</p>
     <p>2. Effect of IAV/
      <italic>M tuberculosis</italic> co‐infection on control of TB
     </p>
    </td>
    <td align="left" rowspan="2" colspan="1">
     <p>Model: mice</p>
     <p>1. Experimental group: 
      <list list-type="bullet" id="irv12670-list-0016">
       <list-item>
        <p>Intranasal IAV on D1, aerosolized MTB on D28</p>
       </list-item>
      </list>
     </p>
     <p>Control group: 
      <list list-type="bullet" id="irv12670-list-0017">
       <list-item>
        <p>Intranasal placebo (phosphate‐buffered saline [PBS]) on D1, MTB on D28</p>
       </list-item>
      </list>
     </p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0018">
       <list-item>
        <p>lung inflammation, survival, number of viable bacteria in lung tissue</p>
       </list-item>
      </list>
     </p>
     <p>2. Experimental group 2: 
      <list list-type="bullet" id="irv12670-list-0019">
       <list-item>
        <p>Aerosolized MTB D1, intranasal IAV (subtype (Cal/09) on D1 and IAV (subtype X3) on D14</p>
       </list-item>
      </list>
     </p>
     <p>Control group: 
      <list list-type="bullet" id="irv12670-list-0020">
       <list-item>
        <p>Aerosolized MTB D1, placebo (PBS) on D1 and D14</p>
       </list-item>
      </list>
     </p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0021">
       <list-item>
        <p>Number of viable MTB measured on D27</p>
       </list-item>
      </list>
     </p>
    </td>
    <td align="left" rowspan="2" colspan="1">Influenza A Virus/ 
     <italic>M tuberculosis</italic>
    </td>
    <td align="left" rowspan="1" colspan="1">Model 1:120 d</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Model 1 
      <list list-type="bullet" id="irv12670-list-0022">
       <list-item>
        <p>Experimental group 1 had significant increase in inflammation, decreased survival, higher number viable MTB in lung compared to the control group</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Model 2:27 d</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Model 2 
      <list list-type="bullet" id="irv12670-list-0023">
       <list-item>
        <p>Experimental group had significantly increased mycobacterial load compared to control group</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Bernard, (1962)
     <xref rid="irv12670-bib-0037" ref-type="ref">37</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>Assessed the effect of influenza infection on TB‐ infected mice.</p>
     <p>Measured TB bacilli per nodule in the sacrificed mice and time from infection to death for the mice that were not sacrificed</p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>Model: Mice</p>
     <p>Experimental group</p>
     <p>Groups 1, 2, 3, 4 and 5 (10 mice in each) 
      <list list-type="bullet" id="irv12670-list-0024">
       <list-item>
        <p>TB challenge at week 1, 2, 3, 4 and 5, respectively. Influenza challenge at week 6. 50% of mice sacrificed 15 d post‐influenza challenge</p>
       </list-item>
      </list>
     </p>
     <p>Group 6 (20 mice)‐ 
      <list list-type="bullet" id="irv12670-list-0025">
       <list-item>
        <p>influenza only challenge at week 6 for all; Not sacrificed</p>
       </list-item>
      </list>
     </p>
     <p>Control groups</p>
     <p>Groups 1, 2, 3, 4 and 5 (10 mice in each) 
      <list list-type="bullet" id="irv12670-list-0026">
       <list-item>
        <p>TB challenge at week 1, 2, 3, 4 and 5, respectively. No influenza challenge</p>
       </list-item>
      </list>
     </p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0027">
       <list-item>
        <p>Number of TB bacilli per nodule in the sacrificed mice</p>
       </list-item>
       <list-item>
        <p>Time from TB infection to death for the mice that were not sacrificed</p>
       </list-item>
      </list>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">H 37 RV strain of TB</td>
    <td align="left" rowspan="1" colspan="1">173 d, 50% of mice in experimental groups 1‐5 sacrificed 15 d post‐influenza challenge</td>
    <td align="left" rowspan="1" colspan="1">
     <list list-type="bullet" id="irv12670-list-0028">
      <list-item>
       <p>Experimental groups had 50%‐75% lower survival time and had increased number of bacilli per nodules. Effect of influenza infection on TB severity increased with increasing duration of TB infection before influenza challenge</p>
      </list-item>
      <list-item>
       <p>Among non‐sacrificed mice, death in 25/25 (100%) co‐infected vs 1/20 (5%) infected with influenza only</p>
      </list-item>
     </list>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Massanari (
     <xref rid="irv12670-bib-0040" ref-type="ref">40</xref>)
    </td>
    <td align="left" rowspan="1" colspan="1">Examined tuberculin hypersensitivity during superimposed acute influenza infection</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Model: Mice</p>
     <p>Experimental groups 1: 
      <list list-type="bullet" id="irv12670-list-0029">
       <list-item>
        <p>Influenza virus, intranasal (i.n.) 4‐6 wk after 
         <italic>M tuberculosis</italic> infection
        </p>
       </list-item>
      </list>
     </p>
     <p>Experimental group 2 
      <list list-type="bullet" id="irv12670-list-0030">
       <list-item>
        <p>Formalin‐inactivated influenza virus (i.n.) or intravenous (i.v.) live influenza virus 4‐6 wk after 
         <italic>M tuberculosis</italic> infection
        </p>
       </list-item>
      </list>
     </p>
     <p>Control group</p>
     <p>Inoculated with PBS, 4‐6 wk after 
      <italic>M tuberculosis</italic> infection
     </p>
     <p>Outcomes: 
      <list list-type="bullet" id="irv12670-list-0031">
       <list-item>
        <p>Tuberculin hypersensitivity (measured as footpad swelling) 6 d after influenza, PBS challenge</p>
       </list-item>
       <list-item>
        <p>Number of circulating lymphocytes post‐influenza challenge</p>
       </list-item>
      </list>
     </p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <italic>M tuberculosis</italic> and influenza A/PR8
    </td>
    <td align="left" rowspan="1" colspan="1">4‐6 wk after TB infection</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Experimental group 1 
      <list list-type="bullet" id="irv12670-list-0032">
       <list-item>
        <p>Suppressed tuberculin hypersensitivity from D3 to D16 post–intranasal influenza infection. Suppression of immune response preceded presentation of clinical signs of influenza</p>
       </list-item>
       <list-item>
        <p>Reduction in lymphocytes on D 2, 5, 7 post‐influenza challenge compared to values before influenza infection</p>
       </list-item>
      </list>
     </p>
     <p>Experimental group 2 
      <list list-type="bullet" id="irv12670-list-0033">
       <list-item>
        <p>No immunosuppression in experimental group 2</p>
       </list-item>
      </list>
     </p>
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Co (2006)
     <xref rid="irv12670-bib-0041" ref-type="ref">41</xref>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>Tested how BCG‐specific and influenza‐specific CD4 T</p>
     <p>cells distribute between the two inflammatory sites (lungs and liver), how these two T cells would interfere with each other and how these interactions affect granuloma formation, dissemination,</p>
     <p>and control of BCG</p>
    </td>
    <td align="left" rowspan="1" colspan="1">
     <p>Model: Mice</p>
     <p>Experimental groups: 
      <list list-type="bullet" id="irv12670-list-0034">
       <list-item>
        <p>Mice chronically infected with BCG and intranasal hen egg lysozyme (HEL‐flu) influenza challenge 5 wk post‐BCG</p>
       </list-item>
       <list-item>
        <p>Mice chronically infected with BCG and wild type (wt) influenza challenge 5 wk post‐BCG</p>
       </list-item>
      </list>
     </p>
     <p>Control group: 
      <list list-type="bullet" id="irv12670-list-0035">
       <list-item>
        <p>Mice infected with BCG alone</p>
       </list-item>
      </list>
     </p>
     <p>Outcome:</p>
     <p>Number of AFB per lesion, number of granuloma lesions and dissemination of mycobacteria from granuloma</p>
    </td>
    <td align="left" rowspan="1" colspan="1">HEL‐flu or wt. influenza virus/ BCG</td>
    <td align="left" rowspan="1" colspan="1">5 wk 6 d</td>
    <td align="left" rowspan="1" colspan="1">
     <p>Experimental groups 
      <list list-type="bullet" id="irv12670-list-0036">
       <list-item>
        <p>Increase in numbers of granulomas/field (granuloma burden) in experimental groups compared to controls</p>
       </list-item>
       <list-item>
        <p>Slight increase in number of AFB per lesion compared to the control group</p>
       </list-item>
       <list-item>
        <p>No dissemination of mycobacteria from granuloma</p>
       </list-item>
      </list>
     </p>
     <p>Interpretation: Co‐infection with influenza had little effect on mycobacterial load mycobacteria did not disseminate in either group</p>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="irv12670-ntgp-0003">
  <fn id="irv12670-note-0007">
   <p>Abbreviations: BCG, Calmette‐Guerin; HEL, hen egg lysozyme; IAV, influenza A virus; IFN, interferon; 
    <italic>M tuberculosis</italic>, 
    <italic>Mycobacterium tuberculosis</italic>; TB, tuberculosis.
   </p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
